StockData
Lipocine Inc. logo

Lipocine Inc. (LPCN) stock

LPCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3048% below fair value
$1.71+0.09 (+5.56%)

Close on Nov 13, 2026Market cap $14.10MP/E –Yield –

Lipocine statistics

74 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 9, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 13, 2026

Valuation ratiosIndustry

Market Cap
$14.10M
$272.32M
Enterprise Value
-$7.36M
$146.23M
PS Ratio
3.76
3.66
PB Ratio
0.67
2.00
P/TBV Ratio
0.67
2.22

Enterprise valuationIndustry

EV / Sales
-1.96
2.57

Share statisticsIndustry

Shares Change (YoY)
37.5%
10.8%
Shares Change (QoQ)
0.01%
0.50%
Float
8M
49M
Shares Held by Insiders
8.41%
11.7%
Shares Held by Institutions
36.2%
56.4%

Short sellingIndustry

Short Interest
325,401
–
Short Interest Change
-7.41%
-0.80%
Short % of Float
4.31%
9.01%
Short % of Shares Outstanding
3.95%
6.30%
Days to Cover
1.50
5.15

Stock price statisticsIndustry

52-Week High
$12.37
–
52-Week Low
$1.36
–
20-Day Moving Average
$1.54
–
50-Day Moving Average
$1.86
–
200-Day Moving Average
$3.48
–
Average True Range (14)
$0.14
–
Price Change (1 Week)
8.92%
-1.15%
Price Change (1 Month)
1.79%
-4.87%
Price Change (3 Months)
-16.6%
-21.0%
Price Change (6 Months)
-24.3%
-20.6%
Price Change (YTD)
-78.7%
-23.6%
Price Change (1 Year)
-41.4%
-22.4%
Price Change (3 Years)
-36.3%
-29.5%
Price Change (5 Years)
-91.5%
-77.9%
Price Change (10 Years)
-97.4%
-65.4%
Average Volume (10 Days)
241,098
–
Average Volume (20 Days)
219,979
–
Average Volume (90 Days)
1M
–
Relative Volume
0.16
0.70
Relative Strength Index (14)
54.0
43.4
Volatility (1 Year)
109.9%
80.1%
Beta (5 Years)
0.66
1.07

MarginsIndustry

Operating Margin
-269.1%
-38.7%
Pretax Margin
-249.1%
-11.6%
Profit Margin
-249.2%
-31.6%
EBITDA Margin
-267.5%
-27.7%

Returns on capitalIndustry

Return on Equity (ROE)
-52.9%
-49.9%
Return on Assets (ROA)
-47.5%
-40.6%
Return on Capital Employed (ROCE)
-47.6%
-37.9%

Financial positionIndustry

Current Ratio
11.36
3.30
Quick Ratio
10.55
2.39

GrowthIndustry

Revenue Growth (YoY)
-13.4%
6.82%
Revenue Growth (3Y CAGR)
58.1%
2.25%

EfficiencyIndustry

Asset Turnover
0.19
0.40
Revenue Per Employee
$267.50K
$429.29K
Profits Per Employee
-$666.48K
-$689.41K
Employee Count
14
74
WACC
8.41%
10.2%

Income statement (TTM)Industry

Revenue
$3.74M
$66.37M
Operating Income
-$10.08M
-$21.37M
Pretax Income
-$9.33M
-$12.95M
Net Income
-$9.33M
-$22.35M
EBITDA
-$10.02M
-$17.21M
EPS (Diluted)
-$1.29
-$0.76

Balance sheetIndustry

Net Cash (Debt)
$21.46M
$17.76M
Net Cash Per Share
$2.60
$0.80
Equity (Book Value)
$21.16M
$53.89M
Book Value Per Share
$2.57
$1.50
Tangible Book Value
$21.16M
$27.13M
Working Capital
$21.08M
$79.99M

Cash flow (TTM)Industry

Operating Cash Flow
-$10.01M
-$12.38M

Dividends and yieldsIndustry

Earnings Yield
-66.2%
-21.8%
Buyback Yield
-114.4%
-0.76%
Shareholder Yield
-114.4%
0.00%

Scores and fair valueIndustry

Altman Z-Score
-9.08
0.23
Piotroski F-Score
1
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodLPCNS&P 500DifferenceLPCN per yearS&P 500 per year
1 month+5.6%-3.0%+8.6 pts
3 months-17.0%-2.8%−14.2 pts
Year to date-78.7%+11.5%−90.2 pts
1 year-39.4%+13.5%−52.8 pts
3 years-38.5%+77.7%−116.2 pts-15.0%+21.1%
5 years-91.5%+72.6%−164.2 pts-39.0%+11.5%
10 years-97.2%+308.2%−405.3 pts-30.0%+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M LPCN shares were sold short on Oct 30, 2026, down 7.4% from the previous report, or 4.31% of the shares available to trade. At recent volumes it would take 1.5 days to buy them back. Over the last 20 sessions, 30.8% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 2026325,401-7.4%216,6491.5
Oct 15, 2026351,433+259.3%9,616,8951.0
Sep 30, 202697,816-1.6%43,2792.3
Sep 15, 202699,444-1.5%21,6904.6
Aug 31, 2026100,992+7.0%33,5323.0
Aug 14, 202694,427-14.9%50,3421.9
Jul 31, 2026110,962-9.8%31,1673.6
Jul 15, 2026123,024-13.2%41,2013.0
Jun 30, 2026141,719-7.0%86,4891.6
Jun 15, 2026152,344+68.8%125,4661.2
May 29, 202690,238-11.6%83,4891.1
May 15, 2026102,133-41.2%103,7621.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?